224 related articles for article (PubMed ID: 33482809)
1. Cofilin-1, LIMK1 and SSH1 are differentially expressed in locally advanced colorectal cancer and according to consensus molecular subtypes.
Sousa-Squiavinato ACM; Vasconcelos RI; Gehren AS; Fernandes PV; de Oliveira IM; Boroni M; Morgado-Díaz JA
Cancer Cell Int; 2021 Jan; 21(1):69. PubMed ID: 33482809
[TBL] [Abstract][Full Text] [Related]
2. LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance.
Aggelou H; Chadla P; Nikou S; Karteri S; Maroulis I; Kalofonos HP; Papadaki H; Bravou V
Virchows Arch; 2018 May; 472(5):727-737. PubMed ID: 29352327
[TBL] [Abstract][Full Text] [Related]
3. SSH3 facilitates colorectal cancer cell invasion and metastasis by affecting signaling cascades involving LIMK1/Rac1.
Hu YH; Lu YX; Zhang ZY; Zhang JM; Zhang WJ; Zheng L; Lin WH; Zhang W; Li XN
Am J Cancer Res; 2019; 9(5):1061-1073. PubMed ID: 31218112
[TBL] [Abstract][Full Text] [Related]
4. Role of SSH1 in colorectal cancer prognosis and tumor progression.
Song X; Xie D; Xia X; Tan F; Pei Q; Li Y; Zhou Z; Zhou Y; Li C; Wang K; Pei H
J Gastroenterol Hepatol; 2020 Jul; 35(7):1180-1188. PubMed ID: 32020663
[TBL] [Abstract][Full Text] [Related]
5. LIMK1: A promising prognostic and immune infiltration indicator in colorectal cancer.
Liu X; Song Q; Wang D; Liu Y; Zhang Z; Fu W
Oncol Lett; 2022 Jul; 24(1):234. PubMed ID: 35720504
[TBL] [Abstract][Full Text] [Related]
6. The correlation between immune subtypes and consensus molecular subtypes in colorectal cancer identifies novel tumour microenvironment profiles, with prognostic and therapeutic implications.
Soldevilla B; Carretero-Puche C; Gomez-Lopez G; Al-Shahrour F; Riesco MC; Gil-Calderon B; Alvarez-Vallina L; Espinosa-Olarte P; Gomez-Esteves G; Rubio-Cuesta B; Sarmentero J; La Salvia A; Garcia-Carbonero R
Eur J Cancer; 2019 Dec; 123():118-129. PubMed ID: 31678770
[TBL] [Abstract][Full Text] [Related]
7. Phenotypic subtypes predict outcomes in colorectal cancer.
Kasurinen J; Beilmann-Lehtonen I; Kaprio T; Hagström J; Haglund C; Böckelman C
Acta Oncol; 2023 Mar; 62(3):245-252. PubMed ID: 36867078
[TBL] [Abstract][Full Text] [Related]
8. Interconnectivity between molecular subtypes and tumor stage in colorectal cancer.
Coebergh van den Braak RRJ; Ten Hoorn S; Sieuwerts AM; Tuynman JB; Smid M; Wilting SM; Martens JWM; Punt CJA; Foekens JA; Medema JP; IJzermans JNM; Vermeulen L
BMC Cancer; 2020 Sep; 20(1):850. PubMed ID: 32887573
[TBL] [Abstract][Full Text] [Related]
9. Upregulation of LIMK1 Is Correlated With Poor Prognosis and Immune Infiltrates in Lung Adenocarcinoma.
Lu G; Zhou Y; Zhang C; Zhang Y
Front Genet; 2021; 12():671585. PubMed ID: 34149814
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-384 inhibits the progression of esophageal squamous cell carcinoma through blockade of the LIMK1/cofilin signaling pathway by binding to LIMK1.
Yu HX; Wang XL; Zhang LN; Zhang J; Zhao W
Biomed Pharmacother; 2019 Jan; 109():751-761. PubMed ID: 30551528
[TBL] [Abstract][Full Text] [Related]
11. Clinical Value of Consensus Molecular Subtypes in Colorectal Cancer: A Systematic Review and Meta-Analysis.
Ten Hoorn S; de Back TR; Sommeijer DW; Vermeulen L
J Natl Cancer Inst; 2022 Apr; 114(4):503-516. PubMed ID: 34077519
[TBL] [Abstract][Full Text] [Related]
12. Investigation of colorectal cancer in accordance with consensus molecular subtype classification.
Sawayama H; Miyamoto Y; Ogawa K; Yoshida N; Baba H
Ann Gastroenterol Surg; 2020 Sep; 4(5):528-539. PubMed ID: 33005848
[TBL] [Abstract][Full Text] [Related]
13. LIM kinase 1 interacts with myosin-9 and alpha-actinin-4 and promotes colorectal cancer progression.
Liao Q; Li R; Zhou R; Pan Z; Xu L; Ding Y; Zhao L
Br J Cancer; 2017 Aug; 117(4):563-571. PubMed ID: 28664914
[TBL] [Abstract][Full Text] [Related]
14. Classification of colorectal cancer consensus molecular subtypes using attention-based multi-instance learning network on whole-slide images.
Xu H; Wu A; Ren H; Yu C; Liu G; Liu L
Acta Histochem; 2023 Aug; 125(6):152057. PubMed ID: 37300984
[TBL] [Abstract][Full Text] [Related]
15. Classification of patients with metastatic colorectal cancer into consensus molecular subtypes into real-world: A pilot study.
González-Montero J; Burotto M; Valenzuela G; Mateluna D; Buen-Abad F; Toro J; Barajas O; Marcelain K
World J Clin Oncol; 2023 Oct; 14(10):409-419. PubMed ID: 37970108
[TBL] [Abstract][Full Text] [Related]
16. The clinical significance of CCBE1 expression in human colorectal cancer.
Zhao YR; Liu H; Xiao LM; Jin CG; Zhang ZP; Yang CG
Cancer Manag Res; 2018; 10():6581-6590. PubMed ID: 30555263
[TBL] [Abstract][Full Text] [Related]
17. Increased expression of formin-like 3 contributes to metastasis and poor prognosis in colorectal carcinoma.
Zeng YF; Xiao YS; Lu MZ; Luo XJ; Hu GZ; Deng KY; Wu XM; Xin HB
Exp Mol Pathol; 2015 Apr; 98(2):260-7. PubMed ID: 25758200
[TBL] [Abstract][Full Text] [Related]
18. The prognostic impact of consensus molecular subtypes (CMS) and its predictive effects for bevacizumab benefit in metastatic colorectal cancer: molecular analysis of the AGITG MAX clinical trial.
Mooi JK; Wirapati P; Asher R; Lee CK; Savas P; Price TJ; Townsend A; Hardingham J; Buchanan D; Williams D; Tejpar S; Mariadason JM; Tebbutt NC
Ann Oncol; 2018 Nov; 29(11):2240-2246. PubMed ID: 30247524
[TBL] [Abstract][Full Text] [Related]
19. Claudin gene expression profiles and clinical value in colorectal tumors classified according to their molecular subtype.
Cherradi S; Martineau P; Gongora C; Del Rio M
Cancer Manag Res; 2019; 11():1337-1348. PubMed ID: 30863148
[TBL] [Abstract][Full Text] [Related]
20. High Expression of LTBP2 Contributes to Poor Prognosis in Colorectal Cancer Patients and Correlates with the Mesenchymal Colorectal Cancer Subtype.
Huang Y; Wang G; Zhao C; Geng R; Zhang S; Wang W; Chen J; Liu H; Wang X
Dis Markers; 2019; 2019():5231269. PubMed ID: 30956730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]